John Friend
Vorstandsvorsitzender bei KAZIA THERAPEUTICS LIMITED
Profil
John E.
Friend is currently the Chief Executive Officer at Kazia Therapeutics Ltd.
Prior to his current position, he served as the Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
He then worked as the Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018, and again from 2020 to 2021.
Additionally, he held the position of Chief Medical Officer at Druggability Technologies Holdings Ltd.
(New Jersey).
Dr. Friend obtained his undergraduate degree from Southern Methodist University and his doctorate from Robert Wood Johnson Medical School.
Aktive Positionen von John Friend
Unternehmen | Position | Beginn |
---|---|---|
KAZIA THERAPEUTICS LIMITED | Vorstandsvorsitzender | 01.05.2023 |
Ehemalige bekannte Positionen von John Friend
Unternehmen | Position | Ende |
---|---|---|
CELLECTAR BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.11.2021 |
CELLECTAR BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.11.2018 |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2017 |
Druggability Technologies Holdings Ltd. (New Jersey) | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von John Friend
Southern Methodist University | Undergraduate Degree |
Robert Wood Johnson Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
KAZIA THERAPEUTICS LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Health Technology |
Druggability Technologies Holdings Ltd. (New Jersey) |